Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Adipose Tissue Derived Mesenchymal Stromal Cells on Autism and Leaky Gut Syndrome. A Phase I Pilot Study.

NCT05602116 is registered in ClinicalTrials.gov with Cell to Cure ApS as lead sponsor.

NCT NCT05602116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05602116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Adipose Tissue Derived Mesenchymal Stromal Cells on Autism and Leaky Gut Syndrome. A Phase I Pilot Study.
Lead sponsor
Cell to Cure ApS
Phase
Phase 1
Overall status
Completed
Start date
June 9, 2023
Completion date
September 20, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, gastrointestinal dysfunction, inflammatory bowel diseases, leaky gut syndrome, mesenchymal stromal cells